Form 4: Humana Inc. Executive Sanjay K. Shetty Reports Acquisition of Common Stock and Derivative Securities
SEC Form 4 Filing
Sanjay K. Shetty, President of CenterWell at Humana Inc., reports acquiring 4,205 shares of Humana common stock and holding derivative securities including options and restricted stock units.
Summary
- Sanjay K. Shetty, an officer at Humana Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates that Shetty acquired 4,205 shares of Humana common stock on February 24, 2025.
- Following the transaction, Shetty beneficially owns 11,566 shares of Humana common stock.
- Shetty also holds options to purchase 3,964 shares at $487.1602, exercisable from April 1, 2030, and options to purchase 6,572 shares at $367.21, exercisable from February 21, 2031.
- Additionally, Shetty holds 308 restricted stock units, each representing a contingent right to receive one share of Humana Inc. common stock.
- The restricted stock units vest in annual increments.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating stock acquisition by an officer, which can be seen as a slightly positive sign of confidence, but it's not a major event.
Positives
- The acquisition of Humana common stock by a company officer could be interpreted as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The reported transactions may have a minor positive impact on shareholder sentiment, as they reflect an executive's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | Date of grant for incentive and non-qualified stock options vesting in three annual increments from 4/1/24 to 4/1/26. |
| 12/15/2023 | 33% of restricted stock units granted on 4/1/2023 vesting date. |
| 02/21/2024 | Date of grant for incentive and non-qualified stock options vesting in three annual increments from 2/21/25 to 2/21/27. |
| 04/01/2024 | First vesting date for stock options granted on 4/1/2023. |
| 12/15/2024 | 33% of restricted stock units granted on 4/1/2023 vesting date. |
| 02/24/2025 | Date of transaction: Acquisition of Humana Common stock. |
| 02/26/2025 | Date of Form 4 filing. |
| 12/15/2025 | 33% of restricted stock units granted on 4/1/2023 vesting date. |
| 04/01/2026 | Final vesting date for stock options granted on 4/1/2023. |
| 02/21/2027 | Final vesting date for stock options granted on 2/21/2024. |
| 04/01/2030 | Expiration date for stock options with exercise price of $487.1602. |
| 02/21/2031 | Expiration date for stock options with exercise price of $367.21. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.